Paul Anthony Williams - Feb 28, 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
SVP, Products Business
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 28, 2025
Transactions value $
-$3,725
Form type
4
Date filed
3/4/2025, 04:06 PM
Previous filing
Jul 10, 2024
Next filing
Mar 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$2.86K -382 -1.57% $7.48 24K Feb 28, 2025 Direct F1
transaction EBS Common Stock Tax liability -$868 -116 -0.48% $7.48 23.8K Mar 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units